![]() |
|||||||
| Immunocytochemical Grade Antibodies | ||||
| Catalog # | Description | Host | Quantity | Price (US$) |
| AS-3922S | Delta Opioid Receptor Antiserum | Rabbit | 0.1 ml | $ 220.00 |
| AS-3922G | IgG Fraction of AS-3922S | 0.1 ml equiv. | 604.00 |
|
| AS-3964S | Kappa Opioid Receptor Antiserum | Rabbit | 0.1 ml | 220.00 |
| AS-3964G | IgG Fraction of AS-3964S | 0.1 ml equiv. | 604.00 |
|
| AS-3942S | Mu Opioid Receptor Antiserum | Rabbit | 0.1 ml | 220.00 |
| AS-3942G | IgG Fraction of AS-3942S | 0.1 ml equiv. | 604.00 |
|
| Immunoprecipitating Grade Antibody | ||||
| Catalog # | Description | Host | Quantity | Price (US$) |
| IP-3922 | Delta Opioid Receptor Antiserum | Rabbit | 0.1 ml | $ 353.00 |
| (carboxyl terminal: human, rat) | 1.0 ml | 2027.00 |
||
| IP-3964 | Kappa Opioid Receptor Antiserum | Rabbit | 0.1 ml | 353.00 |
| (carboxyl terminal: human, rat) | 1.0 ml | 2027.00 |
||
| IP-3942 | Mu Opioid Receptor Antiserum | Rabbit | 0.1 ml | 353.00 |
| (carboxyl terminal: human, rat) | 1.0 ml | 2027.00 |
||
| Western Blot Reagents | ||||
| Catalog # | Description | Quantity | Price (US$) |
|
| WR-3922 | Delta Opioid Receptor | 1 - 6 | $ 258.00 |
|
| 7 - 12 | 236.00 |
|||
| WR-3964 | Kappa Opioid Receptor | 1 - 6 | 258.00 |
|
| 7 - 12 | 236.00 |
|||
| WR-3942 | Mu Opioid Receptor | 1 - 6 | 258.00 |
|
| 7 - 12 | 236.00 |
|||
| Immunofluorescent Assay Kits | ||||
| Catalog # | Description | Quantity | Price (US$) |
|
| K-3922 | Delta Opioid Receptor IFA Kit | 1 - 6 | 440.00 |
|
| 7 - 12 | 410.00 |
|||
| K-3964 | Kappa Opioid Receptor IFA Kit | 1 - 6 | 440.00 |
|
| 7 - 12 | 410.00 |
|||
| K-3942 | Mu Opioid Receptor IFA Kit | 1 - 6 | 440.00 |
|
| 7 - 12 | 410.00 |
|||
| Synthetic Peptides - Also Available in Bulk | ||||
| Catalog # | Description | Quantity | Price (US$) |
|
| PS-3922 | Delta Opioid Receptor Peptide | 1.0 mg | 236.00 |
|
| PS-3964 | Kappa Opioid Receptor Peptide | 0.5 mg | 236.00 |
|
| PS-3942 | Mu Opioid Receptor Peptide | 0.5 mg | 236.00 |
|
© Research & Diagnostic Antibodies 1997 - 2020. All rights reserved. |